Nuvation Bio
New York
About Nuvation Bio
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. It engages in treating patients with the most difficult-to-treat cancers for which conventional therapies have failed.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $927.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2025)
- Ticker: nyse:NUVB
- Website: nuvationbio.com
- Phone: +1 332 208 6102
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nuvation-bio-9972 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.